Cushing Disease clinical trials
11 active trials name this condition. Describe your situation to see which ones look like a fit.
By location
- Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease
- A Trial of Lu AG13909 in Adult Participants With Cushing's Disease
- A Study to Evaluate the Safety and PK of CRN04894 for the Treatment of Cushing's Syndrome
- Fimepinostat, Combination HDAC and Pi3-kinase Inhibitor Tumor-Directed Therapy for Cushing Disease
- DDAVP for Pituitary Adenoma
- FET PET/CT Imaging To Localize Pituitary Adenomas In Cushing Disease
- Desmopressin Stimulation Test Performance in ACTH-Dependent Cushing Syndrome
- Evaluation of Intraoperative Contrast Enhanced Ultrasound for the Identification of Pituitary Adenoma in Cushing's Disease Compared to Other Pituitary Tumors
- Long-Term Follow-Up of Survivors of Pediatric Cushing Disease
- Collecting Information About Treatment Results for Patients With Cushing's Syndrome
- An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Cushing Disease” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.